Esperion Therapeutics, Inc. ( ESPR) - Stock Earnings
ESPR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -31.3 million USD | 87.3 million USD |
| 2025Q4 | 61.8 million USD | 168.4 million USD |
| 2026Q1 | -25.2 million USD | 80.1 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ESPR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -209.2 million USD | 116.3 million USD |
| 2024 | -51.7 million USD | 332.3 million USD |
| 2025 | -22.7 million USD | 403.1 million USD |
| 2026 Est. | — | — |
ESPR
Price: $3.13
52 week price:
Earnings Per Share: -0.11 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 623424
Ebitda: -37.8 millionMarket Capitalization: 805.8 million